Direct Biologics

Austin, United States

Direct Biologics is a market leading innovator and cGMP manufacturer of regenerative biologic products, including ExoFlo.

$35.1M raised

Oct 2022

Series B

Biotechnology Manufacturing Pharmaceutical Product Research

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Direct Biologics

How much funding has Direct Biologics raised?

Direct Biologics has raised $35.1M in total funding. The most recent round was Series B. The last funding was announced in October 2022.

Where is Direct Biologics headquartered?

Direct Biologics is headquartered in Austin, United States.

What does Direct Biologics do?

Direct Biologics is a market leading innovator and cGMP manufacturer of regenerative biologic products, including ExoFlo.

What stage is Direct Biologics at?

Direct Biologics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2022.

MLA

"Direct Biologics — Funding & Investors." VCBacked, October 1, 2022, https://www.vcbacked.co/company/direct-biologics. Accessed July 3, 2026.

APA

VCBacked. (2022). Direct Biologics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/direct-biologics

Wikipedia (cite web)

{{cite web |title=Direct Biologics — Funding & Investors |url=https://www.vcbacked.co/company/direct-biologics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K